Join the UC Davis Office of Research and the UC Davis School of Medicine in a panel discussion about the new Omicron variant of COVID-19, open exclusively to UC Davis faculty, researchers, students and staff. Experts in immunology, epidemiology, public health and infectious diseases will answer audience questions regarding this new variant. Questions can be […]
Join the UC Davis Office of Research and the UC Davis School of Medicine in a discussion with Professor Shabir A. Madhi from University of the Witwatersrand, Johannesburg. Director of the Vaccines & Infectious Diseases Analytics Research Unit, Dr. Madhi will share a unique insight and experience of the Omicron variant, having endured the South […]
February 10, 2022 The University of California, Davis, Office of Research is pleased to announce the appointment of Saif Islam, a professor in the Department of Electrical and Computer Engineering, as the new director of the Center for Information Technology Research in the Interest of Society (CITRIS) at UC Davis, effective January 3, 2022, for a five […]
Join the UC Davis Office of Research in a discussion with Carol Burns, Deputy Director for Research and Chief Research Officer at Lawrence Berkeley National Laboratory. Dr. Burns will discuss her new role with the lab, deep history in research and opportunities for UC Davis researchers to work with the lab. Register for this event […]
The UC Davis Chancellor’s Innovation Awards are designed to recognize faculty, community partners, and industry leaders for their success in developing new technologies, social platforms or other innovations based on university research or academic endeavors. These innovators play an essential role in translating university research to improve the lives of others and address the needs of our […]
Heather Siefkes, assistant professor of pediatric critical care at UC Davis Children’s Hospital, and founder of the startup NeoPOSE, signed a letter of agreement for the exclusive rights to commercialize a new technology developed at UC Davis that could improve the detection of congenital heart defects in newborns. According to the Centers for Disease Control, […]
BridgeBio Pharma, Inc. announced a collaboration with the University of California, Davis (UC Davis), to advance research and the development of investigational medicines for patients with genetically driven conditions and cancers. “UC Davis is a top-tier research university and we feel honored to get the chance to collaborate closely with the talented team there as we work […]
Local startup licensing technology from UC Davis aims to reduce energy costs and environmental impact The University of California, Davis and RePurpose Energy, a clean energy startup, have executed a licensing agreement for an innovative system that repurposes batteries from electric cars to use as energy storage systems with various applications, like solar power. The […]
The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known as COVID-19. The license, negotiated by the InnovationAccess team within the UC Davis Office of Research, provides exclusive access for InVixa to commercialize the technology […]